Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01289717 · ClinicalTrials.gov registry record
Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients
A clinical trial of Kidney Transplantation and Kidney Transplant, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 307
- Enrollment target
- 5
- Study locations
NCT01289717: Completed study of Kidney Transplantation and Kidney Transplant, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT01289717 is a study of Kidney Transplantation and Kidney Transplant that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 307 participants, above the 259-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (19% higher). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01289717, a study of Kidney Transplantation and Kidney Transplant, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 307 participants
- Enrollment target
- 5
- Study locations
Study Summary
There is a need to develop blood and/or urine tests that will help to detect early signs of rejection in people who have had kidney transplant. Researchers will examine blood, urine, and tissue samples and try to identify genetic markers for certain conditions like rejection, response to therapy, and scarring of the kidney. By studying gene patterns, researchers hope to be able to diagnose these conditions earlier and improve kidney survival.
Conditions Studied
Study Locations (5)
Arizona
- Mayo Clinic, Division of Nephrology - Phoenix
California
- The Scripps Research Institute, Scripps Center for Organ and Cell Transplantation, - La Jolla
Illinois
- Northwestern University, Feinberg School of Medicine, Division of Organ Transplantation - Chicago
Ohio
- The Cleveland Clinic - Cleveland
South Carolina
- Medical University of South Carolina, Division of Transplant - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 307 participants |
| Start Date | 2011-03 |
| Est. Completion | 2016-06 |
What the finished NCT01289717 record still lists
NCT01289717 is an observational study that tracks outcomes without assigning an intervention. The registered 307 participants enrollment target is mid-sized for trials with a published cap, above the 259-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (19% higher).
The record links to 2 conditions, with Kidney Transplantation appearing as the primary indexed condition, and to 0 interventions.
NCT01289717 lists 5 locations in 5 states (Arizona, California, Illinois).
Frequently Asked Questions
What is clinical trial NCT01289717 about?
NCT01289717 is a clinical study titled "Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients". There is a need to develop blood and/or urine tests that will help to detect early signs of rejection in people who have had kidney transplant. Researchers will examine blood, urine, and tissue samples and try to identify genetic markers for certain conditions like rejection, response to therapy, an...
What is the current status of trial NCT01289717?
This trial is currently completed. The enrollment target is 307 participants. The study started on 2011-03. Estimated completion is 2016-06.
What conditions does trial NCT01289717 study?
This clinical trial studies the following conditions: Kidney Transplantation, Kidney Transplant.
Who is sponsoring clinical trial NCT01289717?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01289717 being conducted?
This trial has 5 study locations across Arizona, California, Illinois, Ohio, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01289717's enrollment target sits among peer trials
307 9th of 33 higher than 25 of 33 other Kidney Transplantation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Transplantation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.
RECRUITING · Phase 4
-
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
RECRUITING · NA
-
Prehabilitation for Kidney Transplant Candidates
RECRUITING · NA
-
REgulatory T Cell Therapy to Achieve Immunosuppression REduction
RECRUITING · Phase 2
-
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
RECRUITING · Phase 2
-
Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05433142 · 307 participants · Phase 1
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- NCT04162938 · 308 participants · NA
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
- NCT04955795 · 308 participants · NA
Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA
- NCT06090539 · 308 participants · Phase 1
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia